Transcription factor JunB (JUNB)

Transcription factor JunB (JUNB) is a member of the basic leucine zipper (bZIP) family and a core component of the dimeric Activator Protein-1 (AP-1) complex. It regulates gene expression by binding to the AP-1 consensus sequence, either as a homodimer or by heterodimerizing with members of the Fos family [1, 3]. JUNB plays a dual role in physiology and pathology; it is essential for placental development, angiogenesis, and immune cell differentiation, yet it is also implicated in the progression of various cancers such as multiple myeloma and anaplastic large cell lymphoma [1, 5]. In many contexts, JUNB acts as a functional antagonist to c-Jun, often suppressing cell cycle progression, though its overexpression in specific tumors promotes survival and drug resistance [2, 3]. Pharmacological targeting of JUNB is primarily achieved indirectly through the inhibition of upstream MAPK/ERK or PI3K/AKT signaling pathways, which modulate its stability and expression [3, 5]. Direct small-molecule inhibitors of the AP-1 complex, such as T-5224, also represent a potential therapeutic avenue [3]. However, the critical role of JUNB in normal tissue homeostasis and embryonic development presents significant safety challenges for systemic therapeutic interventions [1, 5].

Other names

JunB proto-oncogeneAP-1 transcription factor subunitTranscription factor AP-1 subunit JunBActivator protein 1Jun B proto-oncogene

JUNB is primarily targeted through the inhibition of upstream signaling pathways, such as the MAPK/ERK and PI3K/AKT/mTOR pathways, which regulate its transcriptional and translational expression. Additionally, small molecule inhibitors of the AP-1 complex can disrupt its DNA-binding activity or dimerization with Fos family members.